Advances in counselling and surveillance of patients at risk for pancreatic cancer.
about
Genetic determinants and potential therapeutic targets for pancreatic adenocarcinomaReview of screening for pancreatic cancer in high risk individualsHereditary pancreatitis: current perspectivesKey players in pancreatic cancer-stroma interaction: Cancer-associated fibroblasts, endothelial and inflammatory cellsScreening for pancreatic cancer in familial high-risk individuals: A systematic reviewInherited pancreatic cancer syndromesEmergence of zebrafish models in oncology for validating novel anticancer drug targets and nanomaterialsEarly detection and prevention of pancreatic cancer: is it really possible today?Pancreatic cancer risk in hereditary pancreatitisEndoscopic ultrasonography for surveillance of individuals at high risk for pancreatic cancerPancreatic cancer early detection: expanding higher-risk group with clinical and metabolomics parametersHypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cellsCombining in Vitro Diagnostics with in Vivo Imaging for Earlier Detection of Pancreatic Ductal Adenocarcinoma: Challenges and Solutions.Vascular endothelial growth factor receptor type 2-targeted contrast-enhanced US of pancreatic cancer neovasculature in a genetically engineered mouse model: potential for earlier detection.Endoscopic ultrasonography can diagnose distal biliary strictures without a mass on computed tomography.In vivo diagnosis of murine pancreatic intraepithelial neoplasia and early-stage pancreatic cancer by molecular imaging.[Early pancreatic cancer: can the methods currently available identify this disease?].Screening and detection of pancreatic cancer. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011Recent progress on normal and malignant pancreatic stem/progenitor cell research: therapeutic implications for the treatment of type 1 or 2 diabetes mellitus and aggressive pancreatic cancer.Follow-up of patients with pseudotumoral chronic pancreatitis: outcome and surveillanceMUC4 down-regulation reverses chemoresistance of pancreatic cancer stem/progenitor cells and their progeniesGenetic predisposition to pancreatic cancer.Basic principles and technologies for deciphering the genetic map of cancer.Chemoprevention strategies for pancreatic cancerPancreatic ductal adenocarcinoma: risk factors, screening, and early detection.Pancreatic cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Epidemiology of pancreatic cancer and the role of family historySignificant association between ABO blood group and pancreatic cancer.Novel therapies against aggressive and recurrent epithelial cancers by molecular targeting tumor- and metastasis-initiating cells and their progenies.High-risk population in sporadic pancreatic adenocarcinoma: guidelines for screeningCurrent status of molecular markers for early detection of sporadic pancreatic cancer.Hereditary pancreatic cancer.Screening for pancreatic cancer: current evidence and future directions.Molecular biology of pancreatic cancer.Is health screening beneficial for early detection and prognostic improvement in pancreatic cancer?Potential applications of curcumin and its novel synthetic analogs and nanotechnology-based formulations in cancer prevention and therapy.ABO blood group and chronic pancreatitis risk in the NAPS2 cohort.Deploying mouse models of pancreatic cancer for chemoprevention studiesHereditary pancreatic and hepatobiliary cancersA histomorphologic comparison of familial and sporadic pancreatic cancers.
P2860
Q21129230-884F5248-60F1-45D9-8B07-42E0F2538311Q24630198-06FFAF03-E26D-4AFD-A6A3-B44DC3CDC954Q26739600-12870393-E84D-4BF7-980A-BDD84CA18354Q26766065-D49B9FF5-2D79-4324-AC72-E6EEE76E16D2Q26801172-C33CD724-5094-4FF0-9E8C-DEEEFDB8F376Q26853530-4960AB7D-06D9-4DF7-9EF6-4F745C3DBE29Q26860518-2A2F252E-5D9F-4BBC-B372-19FB689E6E21Q26865704-9086EB48-B185-4181-AEF1-3809AD7B4792Q27003930-5551D7B0-6143-45EC-921E-72245D8187E9Q27010209-2BCE20A5-73B1-4622-B254-C423173AE193Q27022231-4A25B82D-2E3C-4D94-9205-322162DB9A4AQ28393898-2E6E3FB3-321C-41DC-A590-A58B14D82301Q30368922-D985D66C-3953-45C0-BF77-9B11AE075623Q30416185-514ADCFA-3F98-453A-98D2-5A69FB559075Q30483947-97F4E18D-4D65-48E0-AA65-9253FD4F0439Q30501198-2DDC7922-D989-45C7-9B1B-050A05557063Q33351295-BF9F37C3-ADE7-4C91-8CBF-5498F4D726DBQ33666350-95B0BBDA-2AF8-44E5-B6EE-0723ACA32B79Q33719099-E1343172-C5F5-4EB7-AE9C-9F3440CFE3D3Q33887069-D5D15464-8A1B-4A7B-8DA8-10A3FAB3B057Q33938044-70BDD7F2-CF2E-4496-AFEC-BF7E36B57029Q34067868-62C10805-A9D8-47E7-AACA-98FDCA5AECFDQ34074628-D71EA7FA-842C-4EEC-8A4C-A8F8513B978BQ34082960-A5AA2B26-DFC6-4C48-AC20-07E2C3B66AB7Q34093790-1C0090A4-ABAA-402F-BA70-DC5DB410EC8BQ34121237-AE1FD963-8E36-4382-B315-F19B47DCE19FQ34155002-A3522533-AC98-4998-8676-400E236BD136Q34354677-ADEA767D-5298-479C-ABDA-4B178957D58BQ34382586-44C94EC1-33A9-448A-83BC-2BA214A2FE4DQ34452269-1B022ADA-6320-4055-A818-77D6213CB560Q34458903-3C18A63B-E7FC-40CE-B106-BC3042463E7AQ34622718-AE1D8B0D-B851-4766-933C-FFF9866F610CQ35014007-D7639B24-6EC2-42EF-ADFB-74F0597EA807Q35085975-0FBDDF91-720F-4ECD-B7FC-705B8D4C8DD4Q35119157-E41600DE-58DA-49D3-8BBD-E5DEB42E2D58Q35225869-A9748B73-A4DC-4467-BEA3-45360134A50CQ35376422-7F377120-B7D6-4B33-BD19-10B33308565DQ35622126-020C8E02-67D2-4636-A46C-EDCBAC7EAA41Q35692230-3293AE6F-9A3F-4ECE-ABE7-6EB546752877Q35889483-CCE71A5C-6253-4B87-A0A0-AD18B1D66A41
P2860
Advances in counselling and surveillance of patients at risk for pancreatic cancer.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Advances in counselling and surveillance of patients at risk for pancreatic cancer.
@ast
Advances in counselling and surveillance of patients at risk for pancreatic cancer.
@en
type
label
Advances in counselling and surveillance of patients at risk for pancreatic cancer.
@ast
Advances in counselling and surveillance of patients at risk for pancreatic cancer.
@en
prefLabel
Advances in counselling and surveillance of patients at risk for pancreatic cancer.
@ast
Advances in counselling and surveillance of patients at risk for pancreatic cancer.
@en
P2093
P2860
P356
P1433
P1476
Advances in counselling and surveillance of patients at risk for pancreatic cancer.
@en
P2093
David C Whitcomb
Henry T Lynch
John P Neoptolemos
Marcia I Canto
Markus M Lerch
Participants of the Fourth International Symposium of Inherited Diseases of the Pancreas
Randall E Brand
Teresa A Brentnall
Wendy S Rubinstein
P2860
P304
P356
10.1136/GUT.2006.108456
P407
P577
2007-10-01T00:00:00Z